- £119.74bn
- £132.33bn
- $53.82bn
- 71
- 48
- 49
- 57
2019 June 30th | R2020 June 30th | R2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | Interim Report | ARS | ARS |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 44,288 | 38,924 | 56,921 | 65,098 | 53,817 |
Cost of Revenue | |||||
Gross Profit | 26,817 | 22,991 | 38,046 | 43,765 | 31,375 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 28,175 | 25,241 | 31,801 | 30,992 | 30,885 |
Operating Profit | 16,113 | 13,683 | 25,120 | 34,106 | 22,932 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 15,049 | 12,825 | 24,292 | 33,137 | 21,401 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9,520 | 8,628 | 13,676 | 22,400 | 14,324 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 8,306 | 7,956 | 11,304 | 30,900 | 12,921 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8,306 | 7,956 | 11,304 | 30,900 | 12,921 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.68 | 1.81 | 3.31 | 3.91 | 2.62 |
Dividends per Share | |||||
Special Dividends per Share |